Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

130.98
+0.95270.73%
Post-market: 132.061.08+0.82%16:20 EDT
Volume:8K
Turnover:1.10M
Market Cap:537.03M
PE:6.79
High:131.13
Open:130.41
Low:130.38
Close:130.03
52wk High:131.68
52wk Low:90.01
Shares:4.10M
Float Shares:4.10M
Volume Ratio:0.40
T/O Rate:0.20%
Dividend:1.06
Dividend Rate:0.81%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.61
PE(LYR):6.03

Loading ...

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
11 mins ago

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
1 hour ago

FDA Authorizes Abbott's Wearable to Monitor Ketone and Glucose in Diabetes Patients

Reuters
·
1 hour ago

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
1 hour ago

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
1 hour ago

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
1 hour ago

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
2 hours ago

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
2 hours ago

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
2 hours ago

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
2 hours ago

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
4 hours ago

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Yesterday

Political and General News Events from August 25

Reuters
·
Yesterday

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
Yesterday

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Yesterday

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

Reuters
·
Yesterday

WuXi Biologics H1 Net Profit up on Margin Expansion

Reuters
·
Yesterday

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Yesterday

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Yesterday